GURUFOCUS.COM » STOCK LIST » USA » NYSE » Teladoc Health Inc (NYSE:TDOC) » Definitions » Piotroski F-Score
Switch to:

Teladoc Health (NYSE:TDOC) Piotroski F-Score

: 4 (As of Today)
View and export this data going back to 2015. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Teladoc Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Teladoc Health's Piotroski F-Score or its related term are showing as below:

TDOC' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 4

During the past 10 years, the highest Piotroski F-Score of Teladoc Health was 6. The lowest was 2. And the median was 4.


Teladoc Health Piotroski F-Score Historical Data

The historical data trend for Teladoc Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teladoc Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 4.00 3.00 6.00 4.00

Teladoc Health Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 3.00 3.00 4.00 4.00

Competitive Comparison

For the Health Information Services subindustry, Teladoc Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Teladoc Health Piotroski F-Score Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Teladoc Health's Piotroski F-Score falls in comparison to its industry or sector. The grey bar indicates the Piotroski F-Score's extreme value range as defined by GuruFocus.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Net Income was -3101.461 + -73.476 + -3810.071 + -69.228 = $-7,054 Mil.
Cash Flow from Operations was 92.469 + 63.021 + 65.549 + 13.156 = $234 Mil.
Revenue was 592.379 + 611.402 + 637.709 + 629.244 = $2,471 Mil.
Gross Profit was 409.909 + 425.783 + 448.836 + 439.137 = $1,724 Mil.
Average Total Assets from the begining of this year (Mar22)
to the end of this year (Mar23) was
(11092.337 + 8102.775 + 8103.965 + 4345.355 + 4309.147) / 5 = $7190.7158 Mil.
Total Assets at the begining of this year (Mar22) was $11,092 Mil.
Long-Term Debt & Capital Lease Obligation was $1,572 Mil.
Total Current Assets was $1,287 Mil.
Total Current Liabilities was $381 Mil.
Net Income was -133.819 + -84.34 + -10.985 + -6674.523 = $-6,904 Mil.

Revenue was 503.139 + 521.658 + 554.235 + 565.35 = $2,144 Mil.
Gross Profit was 342.866 + 352.617 + 379.25 + 378.325 = $1,453 Mil.
Average Total Assets from the begining of last year (Mar21)
to the end of last year (Mar22) was
(17582.358 + 17611.119 + 17652.579 + 17734.608 + 11092.337) / 5 = $16334.6002 Mil.
Total Assets at the begining of last year (Mar21) was $17,582 Mil.
Long-Term Debt & Capital Lease Obligation was $1,573 Mil.
Total Current Assets was $1,208 Mil.
Total Current Liabilities was $307 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Teladoc Health's current Net Income (TTM) was -7,054. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Teladoc Health's current Cash Flow from Operations (TTM) was 234. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar22)
=-7054.236/11092.337
=-0.6359558

ROA (Last Year)=Net Income/Total Assets (Mar21)
=-6903.667/17582.358
=-0.39264739

Teladoc Health's return on assets of this year was -0.6359558. Teladoc Health's return on assets of last year was -0.39264739. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Teladoc Health's current Net Income (TTM) was -7,054. Teladoc Health's current Cash Flow from Operations (TTM) was 234. ==> 234 > -7,054 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=1572.061/7190.7158
=0.21862371

Gearing (Last Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=1572.943/16334.6002
=0.09629516

Teladoc Health's gearing of this year was 0.21862371. Teladoc Health's gearing of last year was 0.09629516. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar23)=Total Current Assets/Total Current Liabilities
=1286.707/381.344
=3.37413726

Current Ratio (Last Year: Mar22)=Total Current Assets/Total Current Liabilities
=1208.045/306.687
=3.939016

Teladoc Health's current ratio of this year was 3.37413726. Teladoc Health's current ratio of last year was 3.939016. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Teladoc Health's number of shares in issue this year was 162.923. Teladoc Health's number of shares in issue last year was 160.532. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1723.665/2470.734
=0.69763277

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1453.058/2144.382
=0.67761154

Teladoc Health's gross margin of this year was 0.69763277. Teladoc Health's gross margin of last year was 0.67761154. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar22)
=2470.734/11092.337
=0.22274242

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar21)
=2144.382/17582.358
=0.12196214

Teladoc Health's asset turnover of this year was 0.22274242. Teladoc Health's asset turnover of last year was 0.12196214. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Teladoc Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Teladoc Health  (NYSE:TDOC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Teladoc Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Teladoc Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Teladoc Health (NYSE:TDOC) Business Description

Teladoc Health logo
Traded in Other Exchanges
Address
2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.
Executives
Laizer Kornwasser officer: PRESIDENT, ENTERPRISE GROWTH 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Michael Willem Waters officer: CHIEF OPERATING OFFICER 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Vidya Raman-tangella officer: Chief Medical Officer 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Claus Torp Jensen officer: Chief Innovation Officer 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Richard J Napolitano officer: Chief Accounting Officer MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007
Christopher Bischoff director C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Hemant Taneja director 14120 MIRANDA ROAD, LOS ALTOS HILLS CA 94022
Sandra L Fenwick director C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Karen L Daniel director 2801 80TH STREET, KENOSHA WI 53141
Yulun Wang officer: Head of Research & Development 130 B CREMONA DR, GOLETA CA 93117
Glen Tullman director C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Daniel Trencher officer: SVP Corporate Strategy 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Arnnon Geshuri officer: Chief Human Resources Officer 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Christopher Caridi officer: Chief Accounting Officer C/O 111 RIVER STREET, HOBOKEN NJ 07030
Catherine Jacobson director C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577

Teladoc Health (NYSE:TDOC) Headlines

From GuruFocus